有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Salmeterol;Salmaterol;SN-408;GR-33343X;Inaspir
Chemical Name (±)-2-(Hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol
CAS 89365-50-4
Related CAS
Formula C25H37NO4
Structure
Formula Weight 415.57794
Stage 上市-1990
Company GlaxoSmithKline (Originator)
Activity/Mechanism Asthma Therapy, Bronchodilators, RESPIRATORY DRUGS, beta2-Adrenoceptor Agonists
Syn. Route 6
Route 1
the reaction of 4-phenyl-1-butanol (i) with 1,6-dibromohexane by means of nah in thf gives the ether derivative (iii), which is then condensed with 5-(2-amino-1-hydroxyethyl)-2-hydroxybenzyl alcohol (iv) by means of ki and triethylamine in hot dmf.
List of intermediates No.
acetonitrile (ii)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (i)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(4-methoxy-2-[[(trifluoromethyl)sulfonyl]oxy]phenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iv)
Reference 1:
    skidmore, i.f.; lunts, l.h.c.; finch, h.; naylor, a. (glaxo group ltd.); phenethanolamine derivs. be 0899448; de 3414752; es 8609209; fr 2545482; gb 2140800; gb 2176476; jp 1988264443; jp 1994087800; us 4992474; us 5091422 .

Route 2
the friedel-crafts condensation of 2-hydroxybenzoic acid methyl ester (i) with 13c-labeled acetyl chloride (ii) by means of alcl3 in dichloromethane gives 5-acetyl-2-hydroxybenzoic acid methyl ester (iii), which is brominated with br2 in chcl3 yielding the bromoacetyl compound (iv). the condensation of (iv) with the secondary amine (v) by means of diea in thf affords the tertiary amine (vi), which is reduced with liald4 in refluxing ethyl ether to provide the trideuterated triol (vii). finally, this compound is debenzylated by hydrogenation with h2 over pd/c in ethanol.
List of intermediates No.
3-amino-2,2-dimethylpropanamide (i)
5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde; 5-iodo-2-[(2-methoxyethoxy)methoxy]benzaldehyde (ii)
tert-butyl (1s)-2-hydrazino-1-(hydroxymethyl)-2-oxoethylcarbamate (iii)
1,1-dimethyl-2-propynyl 2-oxo-2-phenylacetate (iv)
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (v)
[(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-(4-hydroxyphenyl)propanoate (vi)
(2s)-2-(bromomethyl)oxirane (vii)
2-(5-chloro-2-methoxyphenyl)-5-[4-(trifluoromethyl)phenyl]-2,4-dihydro-3h-1,2,4-triazol-3-one (ii)
4-{[6-(dimethylamino)hexyl]oxy}aniline; n-[6-(4-aminophenoxy)hexyl]-n,n-dimethylamine (iii)
ethyl 4-{[6-(dimethylamino)hexyl]oxy}phenyliminoformate (iv)
ethyl 3-({2-[(tert-butoxycarbonyl)amino]acetyl}amino)propanoate (vi)
ethyl 3-[(2-aminoacetyl)amino]propanoate (vii)
Reference 1:
    goodwin, t.e.; et al.; synthesis of 13c,2h3-salmeterol: an analytical internal standard for pharmacokinetic studies. j label compd radiopharm 2000, 43, 1, 65.

Route 3
the reaction of 4-phenyl-1-butanol (i) with 1,6-dibromohexane (ii) by means of koh and tetrabutylammonium bisulfate gives the butyl hexyl ether (iii), which is condensed with 2-aminoacetaldehyde dimethylacetal (iv) in refluxing toluene yielding 2-[6-(4-phenylbutoxy)hexylamino]acetaldehyde dimethylacetal (v). the protection of the amino group of (v) with n-(benzyloxycarbonyloxy)succinimide and triethylamine in acetone affords the carbamate (vi), which is treated with tsoh in acetone to provide the acetaldehyde derivative (vii). the condensation of (vii) with 6-bromo-2,2-dimethyl-1,3-benzodioxan (viii) (obtained by cyclization of phenol (ix) with acetone and alcl3) by means of mg in thf gives the expected carbinol (x), which is deprotected with h2 over pd/c in methanol yielding the aminoethanol derivative (xi). finally, this compound is treated with hcl in methanol/water to open the 1,3-dioxane ring and afford the target compound.
List of intermediates No.
acetonitrile (ii)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (i)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
1-([[(2s,3r,4s)-7,7-dibromo-3-methoxy-2,4-dimethyl-6-heptenyl]oxy]methyl)benzene; benzyl (2s,3r,4s)-7,7-dibromo-3-methoxy-2,4-dimethyl-6-heptenyl ether (iv)
benzyl (2r,4r)-4-methyl-2-piperidinecarboxylate (v)
(vi)
(vii)
(viii)
[(1s,4r)-4-[2-amino-6-(cyclopropylamino)-9h-purin-9-yl]-2-cyclopenten-1-yl]methyl acetate (ix)
[(1s,4r)-4-[2-amino-6-(cyclopropylamino)-9h-purin-9-yl]-2-cyclopenten-1-yl]methyl methyl carbonate (x)
6-(methylamino)-5,6,7,8-tetrahydro-1,2-naphthalenediol (xi)
Reference 1:
    marquillas olondriz, f.; dalmases barjoan, p.; bessa bellmunt, j. (laboratorios vita, sa); new derivs. of 6-(4-phenylbutoxy)hexylamine and process for producing salmeterol. es 2142771; wo 0018722 .

Route 4
the condensation of n-benzyl-n-[6-(4-phenylbutoxy)hexyl]amine (i) with 5-(bromoacetyl)salicylaldehyde (ii) by means of tea in isopropanol gives the adduct (iii), which is debenzylated and reduced with h2 over pt/c and pd/c in ethanol to afford the target triol.
List of intermediates No.
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (i)
[5-(4-methoxybenzoyl)-1h-pyrrol-3-yl](4-methoxyphenyl)methanone (ii)
ethyl 2-(2,4-bis{[4-(methyloxy)phenyl]carbonyl}-1h-pyrrol-1-yl)acetate (iii)
Reference 1:
    ariza aranda, j.; serra masià, j.; montserrat vidal, c. (laboratorios salvat sa); 6-[4-(phenylbutoxy)]hexylaminomethyl-4-hydroxy-alpha1,alpha3-benzenedimethanol. process for obtaining it and novel intermediates for its preparation. es 2065269 .

Route 5
the condensation of 1,6-dibromohexane (i) with 4-phenyl-1-butanol (ii) by means of naoh under phase transfer catalysis gives 6-(4-phenylbutoxy)hexyl bromide (iii), which is condensed with benzylamine (iv) by means of cs2co3 in hot dmf to yield the secondary amine (v). the condensation of (v) with methyl alpha-bromo 4-acetylsalicylate (vi) by means of diea in refluxing thf affords the tertiary amine (vii), which is submitted to a reductive deuteration by means of deuterated liald4 in thf to provide the trideuterated intermediate (viii). finally this compound is deprotected by hydrogenation with h2 over pd/c in methanol to give rise to the target trideuterated salmeterol.
List of intermediates No.
1-(2,6-dihydroxyphenyl)-1-ethanone (iv)
acetonitrile (i)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (ii)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
1,1-dimethyl-2-propynyl 2-oxo-2-phenylacetate (v)
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (vi)
[(4s)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-(4-hydroxyphenyl)propanoate (vii)
(2s)-2-(bromomethyl)oxirane (viii)
Reference 1:
    molinski, t.f.; stanley, s.d.; improved synthesis of 13c,2h3- and 2h3-salmeterol by cs2co3-mediated monoalkylation of a primary amine. j label compd radiopharm 2002, 45, 9, 755.

Route 6
the condensation of 4-phenyl-1-butanol (i) with 1,6-dibromohexane (ii) by means of nah in thf gives the ether (iii), which is condensed with benzylamine (iv) by means of nai and tea in dmso to yield the secondary amine (v). the condensation of (v) with 5-(bromoacetyl)-2-hydroxybenzaldehyde (vi) in refluxing acetonitrile affords the tertiary amine (vii). the reduction of both carbonyl groups of (vii) by means of nabh4 in methanol affords the dihydroxy amine (viii), which is finally debenzylated by means of h2 over pd/c in the same solvent to provide the target salmeterol.the intermediate 5-(bromoacetyl)-2-hydroxybenzaldehyde (vi) has been obtained by friedel crafts condensation of 2-hydroxybenzaldehyde (ix) with bromoacetyl chloride (x) by means of alcl3 in dichloromethane.
List of intermediates No.
1-(2,6-dihydroxyphenyl)-1-ethanone (iv)
[(3r,4s)-1-benzyl-4-(5-bromo-2-methoxyphenyl)pyrrolidinyl]methanol (ix)
acetonitrile (ii)
methyl 2-(8-amino-4-oxo-5,10-dihydro-4h-imidazo[1,2-a]indeno[1,2-e]pyrazin-10-yl)acetate (i)
5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide; 5-(n,n-dibenzylglycyl)salicylamide (x)
tert-butyl (5s,6r,7r)-5-(2,2-difluoro-1,3-benzodioxol-5-yl)-7-(2-hydroxy-4-methoxyphenyl)-6,7-dihydro-5h-cyclopenta[b]pyridine-6-carboxylate (iii)
1,1-dimethyl-2-propynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate (v)
(2s)-2-(bromomethyl)oxirane (viii)
[5-(4-methoxybenzoyl)-1h-pyrrol-3-yl](4-methoxyphenyl)methanone (vi)
ethyl 2-(2,4-bis{[4-(methyloxy)phenyl]carbonyl}-1h-pyrrol-1-yl)acetate (vii)
Reference 1:
    rong, y.; ruoho, a.e.; a new synthetic approach to salmeterol. synth commun 1999, 29, 12, 2155.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名沙美特罗;英文名Salmeterol;Salmaterol;SN-408;GR-33343X;Inaspir;CAS[89365-50-4]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
华东地区邻苯市场行情上涨
华北地区醋酸价格
华北地区正丁醇市场行情
新型“超分子纳米囊”可减少农药
苯胺跌势难改
华东地区BDO市场僵持整理
诺普信等3家国内企业首登三氟苯
华东地区BDO市场持续僵持
华南地区苯酚市场窄幅上行
PTA止跌在眼前
华北苯酐市场行情
江苏地区顺酐市场行情整理
华东苯酐市场行情
山东地区三氯甲烷价格
山东地区辛醇市场行情
山东地区二氯甲烷市场价格动态
华东地区醋酸价格
河南地区醋酸价格
山东地区醋酸价格
浙江地区醋酸价格
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明